证券记录 · 已归档季度
PSNL
Personalis, Inc. · Healthcare · Medical - Diagnostics & Research
10被追踪持有人
-1Δ持有人
19.31M持有股份
$126.70M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -9.1% ·
股份流向 +1.5% ·
净新建仓位 -10.0%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +6 | 44.71M | $598.60M | +11 | −5 |
| Q1 2026 | 65 | +1 | 39.38M | $250.81M | +9 | −8 |
| Q4 2025 | 64 | +1 | 35.38M | $281.65M | +2 | −1 |
| Q3 2025 | 13 | 0 | 21.61M | $140.91M | — | — |
| Q2 2025 | 10 | -1 | 19.31M | $126.70M | — | −1 |
| Q1 2025 | 8 | -2 | 10.69M | $37.54M | — | −2 |
| Q4 2024 | 10 | 0 | 10.13M | $58.56M | — | — |
| Q3 2024 | 9 | +1 | 11.64M | $62.64M | +2 | −1 |
| Q2 2024 | 8 | — | 8.68M | $10.16M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 7.11M | -1.1% | $46.63M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 5.20M | — | $34.14M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 3.14M | — | $20.58M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 3.14M | — | $20.58M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 3.14M | — | $20.58M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 1.37M | +165.6% | $8.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (被动) | 1.37M | +165.6% | $8.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 1.09M | +25.1% | $7.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (被动) | 687.58K | +252.1% | $4.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 563.24K | -45.5% | $3.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 101.15K | +19.0% | $664,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 56.89K | -48.4% | $373,218 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 211 | — | $1,384 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Fidelity (FMR) ✦ | 211 | — | $1,384 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $2.44M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 140 持有人, 84.04M 股份, $493.33M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据